1. Initiatives to Ensure Proper Use of Drugs

We train our MRs to provide information and we teach them about the proper use and efficacy of our products. With the patient always in mind, we strive to cultivate human resources who can serve as members of team-based healthcare for pharmacotherapy partners.

(1) Role of MRs
Nippon Chemiphar has some 200 MRs across Japan. It strives to supply information promptly to medical institutions through pamphlets and newsletters. To this end, we collect information on drug side effects; provide patient guidance and consultation services on drug use; and disseminate news about medical fee revisions. In similar fashion, we are providing IT-based information to help prevent the spread of the coronavirus. We work to ensure the efficiency of our MRs through ties with medical institutions, particularly core hospitals that are central to regional healthcare.

(2) Platform for Learning
The Company conducts seminars and has study groups for various medical conditions, including dementia and lifestyle-related illnesses. We provide medical professionals with the most up-todate information and opinions related to treatment.

(3) Support Materials
For physicians and pharmacists, we publish a periodical by means of which we share our latest information. We also produce pamphlets that provide guidance on nutrition-related and exercise therapies, as well as health management. Through these materials, we are doing our best to help improve the quality of healthcare.

(4) Response to Inquiries Swift
To ensure accurate and speedy responses to telephone inquiries from medical professionals and patients, we have a customer support office that provides information on the appropriate use of our pharmaceuticals.

2. Strengthening Our Quality Assurance and Supply Systems

In recent years, the domestic pharmaceutical industry has faced an urgent need to restore public trust in generic drugs, due to such issues as quality-related improprieties having been observed among several generic drugmakers. As a result, we are conducting Group-wide efforts to strengthen our quality assurance systems.

To ensure a stable supply of pharmaceuticals, even during surges in demand and natural disasters, we are expanding our pool of API suppliers, carrying out capital investments, and increasing the size of our staff.

3. Quality, Information Paramount

We are working on initiatives to ensure the quality of both generics and proprietary products, as well as to provide information more effectively. At the same time, we are devising ways to improve the visibility and user-friendliness of our products.

Product Initiatives Aimed at Safety and Convenience

1. Matte press-through packaging
Reduced shine makes it easier to read the information and instructions written on the aluminum backing of medication packaging.
2. Universal design font
For sheets of press-through packaging and outer packaging, we use a font that is highly legible, to prevent misreading.

3.Tablet imprint
All tablets have the name of the drug and the maker printed, on the top
and bottom half, respectively, on one side, and the bottom and top half on
the other side. Tablets are scored on both sides.

4.Designed to reduce exposure
After filling a vial with medication, any remaining anti-cancer agent is cleaned away from the outer surface of the vial, which is then wrapped in film.
5.Prevents bottles breaking, contents scattering
Cushioning material is placed at the bottom of the vial before it is covered in shrink-wrap film.